StockData
Immatics N.V. logo

Immatics N.V. (IMTX) stock

IMTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 5, 2026Score 1/30
$6.29+0.12 (+1.94%)

Close on Nov 17, 2026Market cap $843.31MP/E –Yield –

Immatics profit margin

Profit margin (net margin) is net income as a percentage of revenue.

No profit margin figures for Immatics

Immatics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Immatics figures

See a number that looks wrong?